Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Matthew Carpenter and Kevin Gray.
Matthew Carpenter
Connection Strength
7.035
Kevin Gray
  1. Efficacy and Safety of Varenicline for Adolescent Smoking Cessation: A Randomized Clinical Trial. JAMA Pediatr. 2019 12 01; 173(12):1146-1153.
    View in: PubMed
    Score: 0.737
  2. Craving, cue reactivity, and stimulus control among early-stage young smokers: effects of smoking intensity and gender. Nicotine Tob Res. 2014 Feb; 16(2):208-15.
    View in: PubMed
    Score: 0.480
  3. Reactivity to in vivo marijuana cues among cannabis-dependent adolescents. Addict Behav. 2011 Jan-Feb; 36(1-2):140-3.
    View in: PubMed
    Score: 0.390
  4. A pilot randomized study of smokeless tobacco use among smokers not interested in quitting: changes in smoking behavior and readiness to quit. Nicotine Tob Res. 2010 Feb; 12(2):136-43.
    View in: PubMed
    Score: 0.371
  5. Evaluating N-acetylcysteine for early and end-of-treatment abstinence in adult cigarette smokers. Drug Alcohol Depend. 2021 08 01; 225:108815.
    View in: PubMed
    Score: 0.205
  6. A Pilot Randomized Clinical Trial of Remote Varenicline Sampling to Promote Treatment Engagement and Smoking Cessation. Nicotine Tob Res. 2021 05 24; 23(6):983-991.
    View in: PubMed
    Score: 0.204
  7. Cannabis and Alcohol Co-Use in a Smoking Cessation Pharmacotherapy Trial for Adolescents and Emerging Adults. Nicotine Tob Res. 2020 07 16; 22(8):1374-1382.
    View in: PubMed
    Score: 0.193
  8. Nicotine replacement therapy sampling for smoking cessation within primary care: results from a pragmatic cluster randomized clinical trial. Addiction. 2020 07; 115(7):1358-1367.
    View in: PubMed
    Score: 0.186
  9. Sex Differences in Subjective and Behavioral Responses to Stressful and Smoking Cues Presented in the Natural Environment of Smokers. Nicotine Tob Res. 2020 01 27; 22(1):81-88.
    View in: PubMed
    Score: 0.186
  10. An electronic, smart lighter to measure cigarette smoking: A pilot study to assess feasibility and initial validity. Addict Behav. 2019 11; 98:106052.
    View in: PubMed
    Score: 0.180
  11. Methods to reduce the incidence of false negative trial results in substance use treatment research. Curr Opin Psychol. 2019 12; 30:35-41.
    View in: PubMed
    Score: 0.174
  12. Acceptability and compliance with a remote monitoring system to track smoking and abstinence among young smokers. Am J Drug Alcohol Abuse. 2018; 44(5):561-570.
    View in: PubMed
    Score: 0.165
  13. Perceptions of Snus Among US Adult Smokers Given Free Product. Nicotine Tob Res. 2017 Dec 13; 20(1):22-29.
    View in: PubMed
    Score: 0.161
  14. A Naturalistic, Randomized Pilot Trial of E-Cigarettes: Uptake, Exposure, and Behavioral Effects. Cancer Epidemiol Biomarkers Prev. 2017 12; 26(12):1795-1803.
    View in: PubMed
    Score: 0.160
  15. Alcohol consumption as a predictor of reactivity to smoking and stress cues presented in the natural environment of smokers. Psychopharmacology (Berl). 2017 Feb; 234(3):427-435.
    View in: PubMed
    Score: 0.149
  16. A longitudinal, naturalistic study of U.S. smokers' trial and adoption of snus. Addict Behav. 2016 12; 63:82-8.
    View in: PubMed
    Score: 0.146
  17. Snus undermines quit attempts but not abstinence: a randomised clinical trial among US smokers. Tob Control. 2017 03; 26(2):202-209.
    View in: PubMed
    Score: 0.143
  18. Attitudes and interest in technology-based treatment and the remote monitoring of smoking among adolescents and emerging adults. J Smok Cessat. 2017 Jun; 12(2):88-98.
    View in: PubMed
    Score: 0.138
  19. Increasing progesterone levels are associated with smoking abstinence among free-cycling women smokers who receive brief pharmacotherapy. Nicotine Tob Res. 2015 Apr; 17(4):398-406.
    View in: PubMed
    Score: 0.133
  20. An exploratory short-term double-blind randomized trial of varenicline versus nicotine patch for smoking cessation in women. Addiction. 2015 Jun; 110(6):1027-34.
    View in: PubMed
    Score: 0.133
  21. Menstrual cycle phase effects in the gender dimorphic stress cue reactivity of smokers. Nicotine Tob Res. 2015 May; 17(5):607-11.
    View in: PubMed
    Score: 0.129
  22. An open-label pilot trial of N-acetylcysteine and varenicline in adult cigarette smokers. Am J Drug Alcohol Abuse. 2015 Jan; 41(1):52-6.
    View in: PubMed
    Score: 0.127
  23. Affective motives for smoking among early stage smokers. Nicotine Tob Res. 2014 Oct; 16(10):1387-93.
    View in: PubMed
    Score: 0.126
  24. Evaluating the effect of access to free medication to quit smoking: a clinical trial testing the role of motivation. Nicotine Tob Res. 2014 Jul; 16(7):992-9.
    View in: PubMed
    Score: 0.124
  25. Brief, instructional smokeless tobacco use among cigarette smokers who do not intend to quit: a pilot randomized clinical trial. Nicotine Tob Res. 2014 Apr; 16(4):397-405.
    View in: PubMed
    Score: 0.121
  26. Smoking topography and abstinence in adult female smokers. Addict Behav. 2013 Dec; 38(12):2833-6.
    View in: PubMed
    Score: 0.119
  27. Does physician continuity within a clinical trial increase retention and compliance among adolescent smokers? Adolesc Psychiatry (Hilversum). 2013 Apr 01; 3(2).
    View in: PubMed
    Score: 0.116
  28. A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents. Am J Psychiatry. 2012 Aug; 169(8):805-12.
    View in: PubMed
    Score: 0.111
  29. Association between ovarian hormones and smoking behavior in women. Exp Clin Psychopharmacol. 2012 Aug; 20(4):251-7.
    View in: PubMed
    Score: 0.109
  30. Nicotine therapy sampling to induce quit attempts among smokers unmotivated to quit: a randomized clinical trial. Arch Intern Med. 2011 Nov 28; 171(21):1901-7.
    View in: PubMed
    Score: 0.106
  31. Varenicline versus bupropion XL for smoking cessation in older adolescents: a randomized, double-blind pilot trial. Nicotine Tob Res. 2012 Feb; 14(2):234-9.
    View in: PubMed
    Score: 0.103
  32. Bupropion SR and contingency management for adolescent smoking cessation. J Subst Abuse Treat. 2011 Jan; 40(1):77-86.
    View in: PubMed
    Score: 0.098
  33. Attention-deficit/hyperactivity disorder confounds nicotine withdrawal self-report in adolescent smokers. Am J Addict. 2010 Jul-Aug; 19(4):325-31.
    View in: PubMed
    Score: 0.096
  34. Assessment of nicotine dependence among adolescent and young adult smokers: a comparison of measures. Addict Behav. 2010 Nov; 35(11):977-82.
    View in: PubMed
    Score: 0.096
  35. Motivating the unmotivated for health behavior change: a randomized trial of cessation induction for smokers. Clin Trials. 2010 Apr; 7(2):157-66.
    View in: PubMed
    Score: 0.094
  36. N-acetylcysteine (NAC) in young marijuana users: an open-label pilot study. Am J Addict. 2010 Mar-Apr; 19(2):187-9.
    View in: PubMed
    Score: 0.094
  37. Menstrual cycle and cue reactivity in women smokers. Nicotine Tob Res. 2010 Feb; 12(2):174-8.
    View in: PubMed
    Score: 0.092
  38. Laboratory-based, cue-elicited craving and cue reactivity as predictors of naturally occurring smoking behavior. Addict Behav. 2009 Jun-Jul; 34(6-7):536-41.
    View in: PubMed
    Score: 0.088
  39. Determining the impact of cannabis use and severity on tobacco cessation outcomes: study protocol for a prospective tobacco treatment trial. BMC Psychol. 2023 Jan 25; 11(1):25.
    View in: PubMed
    Score: 0.057
  40. Characterization of Salivary Progesterone in Female Smokers. Nicotine Tob Res. 2022 10 26; 24(11):1829-1833.
    View in: PubMed
    Score: 0.056
  41. A pilot feasibility study of a behavioral intervention for nicotine vaping cessation among young adults delivered via telehealth. Drug Alcohol Depend. 2022 03 01; 232:109311.
    View in: PubMed
    Score: 0.053
  42. Examining sex, adverse childhood experiences, and oxytocin on neuroendocrine reactivity in smokers. Psychoneuroendocrinology. 2020 10; 120:104752.
    View in: PubMed
    Score: 0.048
  43. Increases in endogenous progesterone attenuate smoking in a cohort of nontreatment seeking women: An exploratory prospective study. Addict Biol. 2021 03; 26(2):e12918.
    View in: PubMed
    Score: 0.048
  44. The influence of gender and oxytocin on stress reactivity, cigarette craving, and smoking in a randomized, placebo-controlled laboratory relapse paradigm. Psychopharmacology (Berl). 2020 Feb; 237(2):543-555.
    View in: PubMed
    Score: 0.046
  45. Gender differences in responses to cues presented in the natural environment of cigarette smokers. Nicotine Tob Res. 2015 Apr; 17(4):438-42.
    View in: PubMed
    Score: 0.033
  46. Author response. Am J Prev Med. 2013 May; 44(5):e51-3.
    View in: PubMed
    Score: 0.029
  47. Cigarette warning label policy alternatives and smoking-related health disparities. Am J Prev Med. 2012 Dec; 43(6):590-600.
    View in: PubMed
    Score: 0.028
  48. Gender differences in craving and cue reactivity to smoking and negative affect/stress cues. Am J Addict. 2012 May-Jun; 21(3):210-20.
    View in: PubMed
    Score: 0.027
  49. Evidence for greater cue reactivity among low-dependent vs. high-dependent smokers. Addict Behav. 2010 Jul; 35(7):673-7.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.